Keith Mikule
Impact in
- Cell Biology top 2%
- Microtubule and mitosis dynamics
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 19
- PARP inhibition in cancer therapy 13
- Cancer Cells and Metastasis 2
-
- Protein Tyrosine Phosphatases 3
- DNA Repair Mechanisms 3
- Protein Kinase Regulation and GTPase Signaling 3
- Ubiquitin and proteasome pathways 3
- Co-authors
- Stephen Doxsey (3 shared papers)Wendy Zimmerman (1 shared paper)Bénédicte Delaval (1 shared paper)Philipp Kaldis (1 shared paper)Chiang J. Li (3 shared papers)Youzhi Li (3 shared papers)Wěi Li (2 shared papers)Polla Hergert (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (4 papers)Cancer Research (4 papers)European Journal of Cancer (3 papers)Journal of Neuroscience (2 papers)Cell Cycle (2 papers)
- Partner nations
- United StatesSouth KoreaSwitzerland
In The Last Decade
Keith Mikule
27 papers receiving 1.6k citations
Keith Mikule's Hit Papers
Peers
Comparison fields: 5 of 92
- Cell Biology 518
- Oncology 782
- Toxicology 70
- Molecular Biology 999
- Cancer Research 197
Countries citing papers authored by Keith Mikule
This map shows the geographic impact of Keith Mikule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Mikule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Mikule more than expected).
Fields of papers citing papers by Keith Mikule
This network shows the impact of papers produced by Keith Mikule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Mikule. The network helps show where Keith Mikule may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Mikule, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Suppression of cancer relapse and metastasis by inhibiting cancer stemness Hit paper breakdown → | 2015 | 382 |
| 2 | 2005 | 259 | |
| 3 | 2006 | 244 | |
| 4 | 2019 | 178 | |
| 5 | 2018 | 115 | |
| 6 | 2017 | 103 | |
| 7 | 2013 | 85 | |
| 8 | 2002 | 57 | |
| 9 | 2014 | 35 | |
| 10 | 2003 | 28 | |
| 11 | 2006 | 26 | |
| 12 | 1998 | 24 | |
| 13 | 1999 | 24 | |
| 14 | 1996 | 23 | |
| 15 | 2018 | 22 | |
| 16 | 2015 | 13 | |
| 17 | 2019 | 12 | |
| 18 | 2007 | 9 | |
| 19 | Thrombin causes pseudopod detachment via a pathway involving cytosolic phospholipase A2 and 12/15-lipoxygenase products. | 2000 | 8 |
| 20 | 2016 | 8 |
About Keith Mikule
Keith Mikule is a scholar working on Oncology, Molecular Biology, Cell Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (13 papers), Microtubule and mitosis dynamics (5 papers), Protein Tyrosine Phosphatases (3 papers), Ovarian cancer diagnosis and treatment (3 papers), DNA Repair Mechanisms (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cell Biology (518 citations), Oncology (782 citations), Toxicology (70 citations), Molecular Biology (999 citations) and Cancer Research (197 citations). Keith Mikule has collaborated with scholars based in United States, South Korea and Switzerland. Frequent co-authors include Stephen Doxsey, Wendy Zimmerman, Bénédicte Delaval, Philipp Kaldis, Chiang J. Li, Youzhi Li, Wěi Li, Polla Hergert, David Leggett and Sylaja Murikipudi. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, European Journal of Cancer, Journal of Neuroscience and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.